ÓSKARE CAPITAL is a brand that specializes in venture capital investments in Europe, with a focus on innovative companies and teams in the field of novel therapeutics. They are the first fund of its kind, targeting the endocannabinoid system and the supporting services and products in this rapidly growing market. The brand has a unique pipeline of deals and offers a highly favorable legal and regulatory landscape in Europe.

With a target of €50 million, ÓSKARE Fund 1 aims to support spin-outs to Series B and beyond, with a European focus and a global remit. The brand follows best ESG practices and has a management team based in Paris and London, bringing expertise in venture capital, pharmacology, oncology, and systems engineering. ÓSKARE CAPITAL prioritizes investments in scientific innovation and solutions that have strong scientific rationale for leveraging the endocannabinoid system in wellness and medical sectors.

They seek opportunities with high barriers to entry and sustained value, particularly those protected by intellectual property. Experience the future of venture capital with ÓSKARE CAPITAL and join them in unlocking the power of novel therapeutics